Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026)
Hims & Hers Health (HIMS) posted Operating Expenses of $475.1 million for Q1 2026, up 9.16% sequentially from $435.2 million in Q4 2025, and up 27.45% YoY from $372.8 million in Q1 2025.
Hims & Hers Health (HIMS) Operating Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Operating Expenses for 8 years, with the latest figure at $475.1 million in Q1 2026.
- Quarterly Operating Expenses rose 27.45% year-over-year to $475.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 36.78% YoY) and the FY2025 annual result came in at $1.6 billion, up 46.48% from the prior year.
- Operating Expenses advanced to $475.1 million in Q1 2026 per HIMS's latest filing, from $435.2 million in the prior quarter.
- Over five years, Operating Expenses peaked at $475.1 million in Q1 2026 and troughed at $91.7 million in Q1 2022.
- A 5-year average of $260.9 million and a median of $219.2 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses gained 3.41% in 2022, then soared 79.64% in 2023.
- Over 5 years, Operating Expenses stood at $143.9 million in 2022, then soared by 42.04% to $204.5 million in 2023, then surged by 71.65% to $350.9 million in 2024, then grew by 24.02% to $435.2 million in 2025, then grew by 9.16% to $475.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $475.1 million, $435.2 million, and $430.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 578.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 578.00 Mn |
| Mar 31, 2026 | 475.11 Mn |
| Dec 31, 2025 | 435.25 Mn |
| Sep 30, 2025 | 430.25 Mn |
| Jun 30, 2025 | 389.47 Mn |
| Mar 31, 2025 | 372.79 Mn |
| Dec 31, 2024 | 350.95 Mn |
| Sep 30, 2024 | 295.51 Mn |
| Jun 30, 2024 | 245.58 Mn |
| Mar 31, 2024 | 219.19 Mn |
| Dec 31, 2023 | 204.46 Mn |
| Sep 30, 2023 | 195.86 Mn |
| Jun 30, 2023 | 179.39 Mn |
| Mar 31, 2023 | 164.69 Mn |
| Dec 31, 2022 | 143.94 Mn |
| Sep 30, 2022 | 134.44 Mn |
| Jun 30, 2022 | 107.37 Mn |
| Mar 31, 2022 | 91.68 Mn |
| Dec 31, 2021 | 83.66 Mn |
| Sep 30, 2021 | 82.53 Mn |